Predicting tumor infiltrating lymphocyte (TIL) adoptive transfer clinical response in metastatic melanoma patients by T cell subpopulation-based rules

被引:0
|
作者
Mehr, R. [1 ]
Pickman, Y. M. [1 ]
Levy, D. [2 ]
Besser, M. J. [2 ]
机构
[1] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel
[2] He Ella Inst Treatment & Res Melanoma & Skin Canc, Sheba Med Ctr, Tel Aviv, Israel
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:721 / 721
页数:1
相关论文
共 50 条
  • [21] Preclinical development of tumor-infiltrating lymphocyte (TIL) based adoptive cell transfer (ACT) immunotherapy for patients with sarcoma and the potential benefit of anti-CD137 stimulation.
    Nielsen, Morten
    Krarup-Hansen, Anders
    Hovgaard, Dorrit
    Petersen, Michael Mork
    Loya, Anand Chainsukh
    Westergaard, Marie Christine Wulff
    Svane, Inge Marie
    Junker, Niels
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] A randomized, prospective evaluation comparing intensity of lymphodepletion prior to adoptive transfer of tumor infiltrating lymphocytes for patients with metastatic melanoma
    Goff, Stephanie L.
    Dudley, Mark
    Citrin, Deborah E.
    Somerville, Robert
    Wunderlich, John R.
    Danforth, David N.
    Zlott, Daniel A.
    Yang, James C.
    Sherry, Richard Mark
    Kammula, Udai S.
    Klebanoff, Christopher
    Hughes, Marybeth S.
    Restifo, Nicholas P.
    Kwong, Mei Li
    Ilyas, Sadia
    Klemen, Nicholas
    Payabyab, Eden
    Steinberg, Seth M.
    White, Donald E.
    Rosenberg, Steven A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Effect of clinical status and previous treatment of melanoma patients on expansion of TIL for adoptive T-cell therapy
    Peddareddigari, V. R.
    Miller, P. W.
    Nebiyou, B. B.
    Overwijk, W. W.
    Ross, M. I.
    Lee, J. E.
    Gershenwald, J. E.
    Prieto, V. G.
    Hwu, P.
    Radvanyi, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
    Brigitte Dréno
    Amir Khammari
    Agnès Fortun
    Virginie Vignard
    Soraya Saiagh
    Tiffany Beauvais
    Nicolas Jouand
    Sylvain Bercegay
    Sylvain Simon
    François Lang
    Nathalie Labarrière
    Cancer Immunology, Immunotherapy, 2021, 70 : 3015 - 3030
  • [25] Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
    Dreno, Brigitte
    Khammari, Amir
    Fortun, Agnes
    Vignard, Virginie
    Saiagh, Soraya
    Beauvais, Tiffany
    Jouand, Nicolas
    Bercegay, Sylvain
    Simon, Sylvain
    Lang, Francois
    Labarriere, Nathalie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (10) : 3015 - 3030
  • [26] Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell Therapy
    Joseph, Richard W.
    Peddareddigari, Vijay R.
    Liu, Ping
    Miller, Priscilla W.
    Overwijk, Willem W.
    Bekele, Nebiyou B.
    Ross, Merrick I.
    Lee, Jeffrey E.
    Gershenwald, Jeffrey E.
    Lucci, Anthony
    Prieto, Victor G.
    McMannis, John D.
    Papadopoulos, Nicholas
    Kim, Kevin
    Homsi, Jade
    Bedikian, Agop
    Hwu, Wen-Jen
    Hwu, Patrick
    Radvanyi, Laszlo G.
    CLINICAL CANCER RESEARCH, 2011, 17 (14) : 4882 - 4891
  • [27] Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
    Saberian, Chantal
    Amaria, Rodabe N.
    Najjar, Amer M.
    Radvanyi, Laszlo G.
    Haymaker, Cara L.
    Forget, Marie-Andree
    Bassett, Roland L.
    Faria, Silvana C.
    Glitza, Isabella C.
    Alvarez, Enrique
    Parshottam, Sapna
    Prieto, Victor
    Lizee, Gregory
    Wong, Michael K.
    McQuade, Jennifer L.
    Diab, Adi
    Yee, Cassian
    Tawbi, Hussein A.
    Patel, Sapna
    Shpall, Elizabeth J.
    Davies, Michael A.
    Hwu, Patrick
    Bernatchez, Chantale
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [28] Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
    Melissa M Alvarez-Downing
    Suzanne M Inchauste
    Mark E Dudley
    Donald E White
    John R Wunderlich
    Steven A Rosenberg
    Udai S Kammula
    World Journal of Surgical Oncology, 10
  • [29] Adoptive cell transfer (ACT) using tumor infiltrating lymphocytes to target neoantigens in patients with metastatic breast cancer
    Goff, S. L.
    Feldman, S. A.
    Somerville, R.
    Rosenberg, S. A.
    CANCER RESEARCH, 2016, 76
  • [30] Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
    Alvarez-Downing, Melissa M.
    Inchauste, Suzanne M.
    Dudley, Mark E.
    White, Donald E.
    Wunderlich, John R.
    Rosenberg, Steven A.
    Kammula, Udai S.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10